Suchergebnisse - "Kwon, Jennifer M."

PubPharm (97)

1

Long-Term Follow-Up Cares and Check Initiative : A Program to Advance Long-Term Follow-Up in Newborns Identified with a Disease through Newborn Screening

enthalten in: International journal of neonatal screening | 2024

von Lietsch, M. | Chan, K. | Taylor, J. | +11

2

Development and assessment of educational materials for spinal muscular atrophy carrier screening in the Plain community

enthalten in: Journal of genetic counseling | 2024

von Eichten, C. | Kuhl, A. | Baker, M. | +3

3

Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1 : the Phase III SPR1NT trial

enthalten in: Nature medicine | 2022

von Strauss, K. | Farrar, M. | Muntoni, F. | +17

CommentIn: Nat Med. 2022 Jul;28(7):1348-1349. - PMID 35840728

4

Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy : the Phase III SPR1NT trial

enthalten in: Nature medicine | 2022

von Strauss, K. | Farrar, M. | Muntoni, F. | +18

CommentIn: Nat Med. 2022 Jul;28(7):1348-1349. - PMID 35840728

5

An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy

enthalten in: Annals of clinical and translational neurology | 2022

von Kwon, J. | Arya, K. | Kuntz, N. | +12

6

Autoimmune Encephalitis : Distinguishing Features and Specific Therapies

enthalten in: Critical care clinics | 2022

von Co, D. | Kwon, J.

7

Newborn screening for spinal muscular atrophy : The Wisconsin first year experience

enthalten in: Neuromuscular disorders : NMD | 2022

von Baker, M. | Mochal, S. | Dawe, S. | +6

8

An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy

enthalten in: Annals of Clinical and Translational Neurology | 2022

von Kwon, J. | Arya, K. | Kuntz, N. | +11

9

Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy

enthalten in: Muscle & nerve | 2021

von Kichula, E. | Proud, C. | Farrar, M. | +4

10

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE) : an open-label, single-arm, multicentre, phase 3 trial

enthalten in: The Lancet. Neurology | 2021

von Day, J. | Finkel, R. | Chiriboga, C. | +18

CommentIn: Lancet Neurol. 2021 Apr;20(4):251-252. - PMID 33743228

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]